Itamar Medical Ltd Revenue Growth Rates (ITMR), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Itamar Medical Ltd   (ITMR)
 

ITMR's Revenue Growth by Quarter and Year

Itamar Medical Ltd 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ITMR Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
4th Quarter December 41.03
3rd Quarter September 11.00
2nd Quarter June 0.00
1st Quarter March 0.00
FY 52.03





ITMR Revenue fourth quarter 2020 Y/Y Growth Comment
Itamar Medical Ltd achieved in the fourth quarter 2020, above Company average Revenue growth of 31.27% year on year, to $ 41.03 millions.

Looking into fourth quarter 2020 results within Medical Equipment & Supplies industry 37 other companies have achieved higher Revenue growth. While Itamar Medical Ltd ' s Revenue rise of 31.27% ranks overall at the positon no. 719 in the fourth quarter 2020.


ITMR Revenue ( Y/Y Growth %) 2020
 2019 2018 2017
4th Quarter December 31.27 % 29.23 % - -
3rd Quarter September 36.14 % - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   32.27 % 62.63 % - -

Financial Statements
Itamar Medical Ltd 's fourth quarter 2020 Revenue $ 41.03 millions ITMR's Income Statement
Itamar Medical Ltd 's fourth quarter 2019 Revenue $ 31.26 millions Quarterly ITMR's Income Statement


ITMR Revenue (Quarter on Quarter Growth %)

 2020
 2019 2018 2017
4th Quarter December 273.04 % 286.88 % - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   32.27 % 62.63 % - -


Back to ITMR Growth rate Comparisons >> Back to ITMR Growth rate Comparisons >>


Revenue fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #178
Overall #719

Revenue Y/Y Growth Statistics
High Average Low
31.28 % 30.25 % 29.22 %
(Dec 31 2020)   (Dec 31 2019)
Revenue fourth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #38
Healthcare Sector #178
Overall #719
Revenue Y/Y Growth Statistics
High Average Low
31.28 % 30.25 % 29.22 %
(Dec 31 2020)   (Dec 31 2019)

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Itamar Medical Ltd 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
286.67 % 89.93 % -100 %
(Dec 31 2019)  


ITMR's IV. Quarter Q/Q Revenue Comment
Itamar Medical Ltd achieved in the IV. Quarter 2020 above company average sequential Revenue doubling of 273.04%, to $ 41.03 millions, from $11.00 millions in the third quarter.

Within Medical Equipment & Supplies industry only one company achieved higher sequential Revenue growth. While Itamar Medical Ltd 's Revenue growth quarter on quarter, overall rank is 126.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #2
Healthcare Sector #33
Overall #126
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #2
Healthcare Sector #33
Overall #126
Revenue Q/Q Growth Statistics
High Average Low
286.67 % 89.93 % -100 %
(Dec 31 2019)  


ITMR's IV. Quarter Q/Q Revenue Comment
Itamar Medical Ltd achieved in the IV. Quarter 2020 above company average sequential Revenue doubling of 273.04%, to $ 41.03 millions, from $11.00 millions in the third quarter.

Within Medical Equipment & Supplies industry only one company achieved higher sequential Revenue growth. While Itamar Medical Ltd 's Revenue growth quarter on quarter, overall rank is 126.


Itamar Medical Ltd 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2020)		 12 Months Ending
(Dec 31 2019)		 12 Months Ending
 12 Months Ending
 12 Months Ending
Cumulative Revenue 12 Months Ending $ 41.03 $ 31.26 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) 31.28 % 29.22 % - - -
Year on Year Revenue Growth Overall Ranking # 528 # 0 # 0 # 0 # 0
Seqeuential Revenue Change (TTM) 31.28 % 29.22 % - - -
Seq. Revenue Growth (TTM) Overall Ranking # 530 # 0 # 0 # 0 # 0


Cumulative Revenue growth Comment
With 31.28% annual Revenue growth, Itamar Medical Ltd would report a record annual Revenue rise if the fiscal year would end on Dec 31 2020.

In the Healthcare sector 146 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 528.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 27
Healthcare Sector # 147
Overall # 528

Revenue TTM Y/Y Growth Statistics
High Average Low
31.28 %
 30.25 %
29.22 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 148
S&P 500 # 530
Cumulative Revenue growth Comment
With 31.28% annual Revenue growth, Itamar Medical Ltd would report a record annual Revenue rise if the fiscal year would end on Dec 31 2020.

In the Healthcare sector 146 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 528.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 27
Healthcare Sector # 147
Overall # 528

Revenue TTM Y/Y Growth Statistics
High Average Low
31.28 %
30.25 %
29.22 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 148
S&P 500 # 530




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
ITMR's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue rise for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2020
Xenon Pharmaceuticals Inc 54.70%$ 54.701 millions
Progyny Inc 54.02%$ 54.020 millions
Resmed Inc 53.01%$ 53.007 millions
Gritstone Bio Inc 52.49%$ 52.489 millions
Labcorp Holdings Inc 52.02%$ 52.021 millions
Allied Healthcare Products inc 51.90%$ 51.900 millions
Invitae Corporation51.51%$ 51.514 millions
Aethlon Medical Inc 51.13%$ 51.133 millions
La Jolla Pharmaceutical Company51.05%$ 51.048 millions
Nuwellis Inc 49.52%$ 49.525 millions
Chembio Diagnostics Inc 49.28%$ 49.283 millions
10x Genomics Inc 49.05%$ 49.050 millions
Diversicare Healthcare Services Inc 48.40%$ 48.400 millions
Jrsis Health Care Corp48.26%$ 48.259 millions
Atrium Therapeutics Inc 48.24%$ 48.235 millions
Optinose Inc 47.52%$ 47.523 millions
Arbutus Biopharma Corp47.47%$ 47.466 millions
Guided Therapeutics Inc 47.06%$ 47.059 millions
Strongbridge Biopharma plc46.74%$ 46.736 millions
Viemed Healthcare Inc 45.48%$ 45.477 millions
Novocure Limited45.06%$ 45.064 millions
Sarepta Therapeutics Inc 44.97%$ 44.974 millions
Elanco Animal Health Incorporated44.82%$ 44.816 millions
Aclaris Therapeutics Inc 44.29%$ 44.292 millions
Astrazeneca Plc43.40%$ 43.403 millions
Organogenesis Holdings Inc 43.09%$ 43.087 millions
Bionano Genomics Inc 43.02%$ 43.019 millions
Supernus Pharmaceuticals inc 42.92%$ 42.920 millions
Sanara Medtech Inc 42.83%$ 42.827 millions
Hookipa Pharma inc 42.70%$ 42.703 millions


About Itamar Medical Ltd Revenue Growth Rates (ITMR), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.